PubMed, LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
Despite their wide suitability, Hers or Hims might not be a good fit some
Clinical evidence indicates they may slow the progression of diabetic kidney disease, preserving renal health over the long term
Administered once daily, preferably before sleep, via subcutaneous injection
Understanding that the results come from sustained, managed use reframes the whole question of "more." Why more is not the goal Because side effects and tolerance track with dosing, faster is not the same as better
Alzheimers patients receiving ALCAR had improved [12, 38, 39]: Attention and memory Mental agility and focus (reaction time) Speech and behavior Another large review by came to a similar conclusion, though the authors emphasized most improvements were subjective